Status:
RECRUITING
Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers
Lead Sponsor:
Konya City Hospital
Conditions:
Newborn Morbidity
Newborn Complication
Eligibility:
All Genders
1-5 years
Phase:
NA
Brief Summary
In this study, the investigators hypothesize that echocardiographic pathologies observed in infants of diabetic mothers are associated with elevated serum phoenixin-14 levels.
Detailed Description
Phoenixin is a neuropeptide that has been discovered in recent years. It was first identified as a reproductive peptide in 2013. However, subsequent studies have demonstrated that phoenixin plays a re...
Eligibility Criteria
Inclusion
- Infants of diabetic mothers
- Healthy term infants
Exclusion
- Infants whose families did not provide consent
- Infants with a syndromic appearance or congenital heart disease
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06891586
Start Date
September 1 2023
End Date
October 1 2025
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Melek Buyukeren
Konya, Karatay, Turkey (Türkiye), 42020